Assessment of clinical effectiveness and safety of ceftazidime-avibactam in ‐treating multi-drug-resistant infections – A retrospective analysis at a tertiary care hospital in Saudi Arabia
CAZ-AVI use was associated with clinical improvement in carbapenem-resistant Klebsiella pneumonia infections. The low incidence of adverse effects and frequent prescriptions filled by ID specialists support the appropriateness of its use.
Authors
- Amani Khardali (ORCID: https://orcid.org/0000-0002-5611-4782)
- Dalin A. Hassan (ORCID: https://orcid.org/0000-0003-2046-0066)
- Anugeetha Thacheril Mohanan (ORCID: https://orcid.org/0000-0003-1557-6566)
- Ahmed Hassan Suhaqi
- Otilia J.F. Banji (ORCID: https://orcid.org/0000-0003-1669-2147)
- Hilal A. Thaibah (ORCID: https://orcid.org/0000-0002-0793-5445)
- Hanan Bakri (ORCID: https://orcid.org/0000-0003-1156-2511)
- Mohamed Eltaib Elmobark (ORCID: https://orcid.org/0000-0003-0546-6697)
- Moaddey Alfarhan (ORCID: https://orcid.org/0000-0002-7207-7555)
- Mousa Mohammed Hassan Tawhari
- Eman Merghani Ali
- Zamzam O Mashraqi
- Majed Abdu Soliman Akam
- Rafat Fahad Mohammed Hawbani
Institutions
- Armed Forces Hospital (SA)
- King Fahad Central Hospital (SA)
- Jazan University (SA)
Publication Details
- Journal
- Journal of Infection and Public Health
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1016/j.jiph.2025.102841
- Citations
- 1
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.59